Merck & Co., Inc.
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed

News on Merck & Co., Inc.

... the key companies in the market include F. Hoffmann-LA Roche AG; Merck & Co., Inc.; GlaxoSmithKline PLC; Allergan PLC; Pfizer, Inc.; Biocon Ltd.; Bristol-Myers Squibb ...
... million ($262 million) in global sales throughthe first nine months of 2018. RELATED:Merck suits up for another Opdivo showdown with Keytruda liver cancer approval More ...
... Introduction 13.12 Astrazeneca 13.11 F. Hoffmann-La Roche 13.10 Abbvie Inc. 13.9 Merck & Co., Inc. 13.8 Glaxosmithkline PLC 13.7 Eli Lilly and Company 13.6 Teva ...
... Back in November, Merck & Co. said its immuno-oncology star, Keytruda, had topped chemo at lengthening the ...
... presenter of each session is included below. In March 2018, Eisai and Merck (known as MSD outside the United States and Canada), through an affiliate, ...
... today that it has entered into an exclusive global license agreement with Merck Animal Health to develop and commercialize its poly-N-acetyl glucosamine (PNAG) vaccine forRhodococcus ...
... Thompson, the hospital's chief executive, resigned in October from the board of Merck. The company, which makes the blockbuster cancer drug Keytruda, had paid him ...
... fireside chat tofire backwith their own detailed case for the deal.Story Merck & Co. hasn't made a big acquisition lately. But that's not because it ...
Subscribe now for full coverage on Merck & Co., Inc.
Start My Free Trial